Literature DB >> 299979

Noncirrhotic portal hypertension in Felty's syndrome.

T Reisman, J U Levi, R Zeppa, R Clark, R Morton, E R Schiff.   

Abstract

A case of Felty's syndrome with nodular regenerative hyperplasia of the liver, presinusoidal portal hypertension, and bleeding esophageal varices is reported. Increased splenic blood flow may be a contributing factor to the development of the regenerative nodules. The portal hypertension is postulated to be a result of intrahepatic vascular compression.

Entities:  

Mesh:

Year:  1977        PMID: 299979     DOI: 10.1007/bf01072959

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  9 in total

1.  Nodular regenerative hyperplasia of the liver in Felty's syndrome.

Authors:  L M Blendis; M C Parkinson; K B Shilkin; R Williams
Journal:  Q J Med       Date:  1974-01

2.  Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.

Authors:  A Sullivan; H Rheinlander; L R Weintraub
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

3.  "Idiopathic" portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases.

Authors:  J L Boyer; M R Hales; G Klatskin
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

4.  Gaucher's disease and portal hypertension.

Authors:  J E Sales; A H Hunt
Journal:  Br J Surg       Date:  1970-03       Impact factor: 6.939

5.  Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis).

Authors:  W P Mikkelsen; H A Edmondson; R L Peters; A G Redeker; T B Reynolds
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969

6.  Portal hypertension in idiopathic tropical splenomegaly.

Authors:  R Williams
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

Review 7.  The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.

Authors:  H P Ward; M H Block
Journal:  Medicine (Baltimore)       Date:  1971-09       Impact factor: 1.889

8.  Nodular regenerative hyperplasia of the liver.

Authors:  D M Knowles; G I Kaye; G C Godman
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

9.  Portal hypertension in the myeloproliferative syndrome and the reticuloses.

Authors:  S SHALDON; S SHERLOCK
Journal:  Am J Med       Date:  1962-05       Impact factor: 4.965

  9 in total
  7 in total

1.  Nodular regenerative hyperplasia of the liver: coral atoll-like lesions on ultrasound are characteristic in predisposed patients.

Authors:  E Caturelli; G Ghittoni; T V Ranalli; V V Gomes
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

Review 2.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

3.  Oesophageal variceal bleeding in Felty's syndrome associated with nodular regenerative hyperplasia.

Authors:  L M Blendis; D Lovell; C G Barnes; S Ritland; D Cattan; P Vesin
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

4.  Nodular regenerative hyperplasia of the liver following renal transplantation.

Authors:  J E Bredfeldt; A L Havey
Journal:  Dig Dis Sci       Date:  1981-03       Impact factor: 3.199

Review 5.  Portal circulation and portal hypertension.

Authors:  S Sherlock
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

6.  Nodular regenerative hyperplasia of the liver: diagnosis by liver biopsy.

Authors:  A H Qizilbash; M Castelli
Journal:  Can Med Assoc J       Date:  1980-05-24       Impact factor: 8.262

7.  Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study.

Authors:  I R Wanless; V Bernier; M Seger
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.